Iterum Therapeutics plc
SEC CIK 1659323 · ITRM · last insider filing 2025-11-20
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Dunne Michael W. | Director · Chief Scientific Officer | filed 2018 - 2025 |
| Whalen Joseph John | Director | filed 2025 - 2025 |
| Hunt Ronald | Director | filed 2018 - 2025 |
| Fishman Corey N. | Director · President & CEO | filed 2018 - 2024 |
| Hecht Beth | Director | filed 2021 - 2023 |
| Chin Mark | Director | filed 2018 - 2023 |
| Ahrens Brenton Karl | Director | filed 2018 - 2022 |
| Kelly David George | Director | filed 2018 - 2022 |
| Heron Patrick J | Director | filed 2018 - 2020 |
| Healy James | Director | filed 2018 - 2020 |
| Malik Shahzad | Director | filed 2018 - 2020 |
| Canaan X L.P. | Director | filed 2018 - 2020 |
| Canaan Partners X LLC | Director | filed 2018 - 2020 |
| Edick Paul R | Director | filed 2018 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Coyne Christine | Chief Commercial Officer | filed 2025 - 2025 |
| Puttagunta Sailaja | Chief Medical Officer | filed 2021 - 2023 |
| Matthews Judith M. | Chief Financial Officer | filed 2018 - 2023 |
| Schaffnit Jeffrey R. | Chief Commercial Officer | filed 2018 - 2018 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.